Sam Altman’s make-or-break year: can the OpenAI CEO cash in his bet on the future?

Altman’s campaigning for his company coincides with its use of enormous present resources to serve an imagined future ...
BioSpace

5 Investigational Therapies That Could Change the Parkinson’s Landscape

From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...
EuropaWire

Boehringer’s Apecotrep Demonstrates Significant Proteinuria Reduction in Phase II Study, Supporting Phase III Development in Primary FSGS

Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...
EuropaWire

Strategic Partnership Between Alfa Laval and ArianeGroup Targets Efficient Liquid Hydrogen Transfer for Mobility Applications

Alfa Laval and ArianeGroup have signed a co-development agreement to industrialise a liquid hydrogen trailer pump, building on a memorandum signed in December 2024. The project aims to address ...